The GYF domain of CD2BP2 serves as an adapter that recognizes proline-rich sequences in intracellular proteins. Although the T cell adhesion molecule CD2 and the core splicing protein SmB/B were previously shown to interact with CD2BP2-GYF, we are now using a general approach to identify putative GYF domain target sites within the human proteome. The phage display-derived recognition motif for CD2BP2-GYF is PPG(W/F/Y/M/L). SPOT analysis confirmed that the GYF domain interacts with peptides from human proteins containing the consensus site. Epitope mapping by NMR spectroscopy performed for several peptides revealed a conserved binding surface. A direct interaction of the CD2BP2-GYF domain with the novel protein interaction partners PI31 and NPWBP was verified by yeast two-hybrid analysis.The CD2BP2 protein is a cellular adapter protein that was originally identified as a binding partner of the T cell adhesion protein CD2 in the context of T cell signaling (1). Subsequently, a nuclear role for CD2BP2 was suggested, based on reports that identified CD2BP2 as a protein associated with spliceosomal complexes and proteins involved in splicing (2, 3). CD2 and SmB/BЈ share the presence of (R/K/G)XXP-PGX(R/K) motifs that were shown to bind to CD2BP2 in vitro and in vivo (1,3,4). CD2BP2 contains a C-terminal fragment of ϳ60 amino acids that confers binding to these proline-rich sequences. Structurally, this so-called GYF domain represents a small ␣/ protein that displays a set of aromatic residues from a unique bulge-helix-bulge motif creating a hydrophobic pocket accommodating the PPG core of the binding peptide (1,4,5). In addition to this core sequence, the positively charged arginine residues in the vicinity of the PPG motif contribute to binding of the CD2 and SmB/BЈ ligand. Interestingly, the PPPPGHR motifs in CD2 can also be bound by the SH3 domain of the Fyn tyrosine kinase and show that proline-rich sequence recognition has ultimately to be viewed across domain borders (5). Functionally the protein-protein interactions mediated by the PPPPGHR motifs are associated with a modulation in CD2-mediated signaling events, as for example interleukin-2 production (6, 7). In the case of the CD2BP2-SmB/BЈ interaction, it was shown that both proteins colocalize to the nucleus of Jurkat and HeLa cells and that the GYF domain of CD2BP2 can coprecipitate SmB/BЈ from cellular lysates (3). However, CD2BP2 has not been detected in the active spliceosome (8), and its role in splicing or splicingassociated processes is still poorly understood. Because proline-rich sequence recognition is characterized by high off-rates and limited specificity (9), additional intracellular proteins are likely to interact with CD2BP2-GYF. Therefore, we attempted to find new binding partners for CD2BP2 based on the recognition code of its GYF domain. Our results show that in addition to CD2 and SmB/BЈ several human proteins contain high affinity target sites for the CD2BP2-GYF domain. Yeast two-hybrid analyses confirm that two of these novel interacti...